Gut microbiome and nonalcoholic fatty liver diseases

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pediatric Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1038/pr.2014.157PMID 25310763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis

  2014cited by this paper
• NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion.

  2014cited by this paper
• The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43

  2013cited by this paper
• Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula.

  2013cited by this paper
• Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH

  2013cited by this paper
• Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study

  2013cited by this paper
• The role of the gut microbiota in nutrition and health

  2012cited by this paper
• Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis

  2012cited by this paper
• Nutrition, Intestinal Permeability, and Blood Ethanol Levels Are Altered in Patients with Nonalcoholic Fatty Liver Disease (NAFLD)

  2012cited by this paper
• Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection

  2012cited by this paper
• In-feed antibiotic effects on the swine intestinal microbiome

  2012cited by this paper
• VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation

  2012cited by this paper
• Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

  2012cited by this paper
• Novel Evidence for Chronic Exposure to Endotoxin in Human Nonalcoholic Steatohepatitis

  2011cited by this paper
• Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation.

  2011cited by this paper
• Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

  2011cited by this paper
• Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes

  2011cited by this paper
• Enterotypes of the human gut microbiome

  2011cited by this paper
• Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models

  2010cited by this paper
• Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women

  2010cited by this paper
• Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

  2010cited by this paper
• Elevated endotoxin levels in non-alcoholic fatty liver disease

  2010cited by this paper
• Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis

  2010cited by this paper
• Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection.

  2010cited by this paper
• Microbiota and SCFA in Lean and Overweight Healthy Subjects

  2010cited by this paper
• Endotoxin and Plasminogen Activator Inhibitor-1 Serum Levels Associated With Nonalcoholic Steatohepatitis in Children

  2010cited by this paper
• Comparative Genome Analysis of Prevotella ruminicola and Prevotella bryantii: Insights into Their Environmental Niche

  2010cited by this paper
• Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis

  2010cited by this paper
• Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults

  2010cited by this paper
• Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

  2009cited by this paper
• VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet‐induced nonalcoholic steatohepatitis model in mice

  2009cited by this paper
• Toll‐like receptors and their role in gastrointestinal disease

  2009cited by this paper
• The role of pH in determining the species composition of the human colonic microbiota.

  2009cited by this paper
• Monitoring Bacterial Community of Human Gut Microbiota Reveals an Increase in Lactobacillus in Obese Patients and Methanogens in Anorexic Patients

  2009cited by this paper
• Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

  2009cited by this paper
• Human gut microbiota in obesity and after gastric bypass

  2009cited by this paper
• Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats.

  2009cited by this paper
• Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.

  2008cited by this paper
• A core gut microbiome in obese and lean twins

  2008cited by this paper
• Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells.

  2008cited by this paper
• Human colonic microbiota associated with diet, obesity and weight loss

  2008cited by this paper
• Early differences in fecal microbiota composition in children may predict overweight.

  2008cited by this paper
• Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women.

  2008cited by this paper
• Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.

  2007cited by this paper
• Lipopolysaccharide-Binding Protein Plasma Levels and Liver TNF-Alpha Gene Expression in Obese Patients: Evidence for the Potential Role of Endotoxin in the Pathogenesis of Non-Alcoholic Steatohepatitis

  2007cited by this paper
• Metabolic Endotoxemia Initiates Obesity and Insulin Resistance

  2007cited by this paper
• Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in Feces

  2006cited by this paper
• Microbial ecology: Human gut microbes associated with obesity

  2006cited by this paper
• An obesity-associated gut microbiome with increased capacity for energy harvest

  2006cited by this paper
• Obesity alters gut microbial ecology.

  2005cited by this paper
• Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases

  2005cited by this paper
• Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets.

  2004cited by this paper
• Regulation of CYP2E1 by ethanol and palmitic acid and CYP4A11 by clofibrate in primary cultures of human hepatocytes.

  2004cited by this paper
• Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis

  2003cited by this paper
• Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

  2003cited by this paper
• Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis.

  2001cited by this paper
• Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis

  2001cited by this paper
• CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.

  2000cited by this paper
• Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis.

  2000cited by this paper
• Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)--a review.

  1999cited by this paper
• Direct Analysis of Genes Encoding 16S rRNA from Complex Communities Reveals Many Novel Molecular Species within the Human Gut

  1999cited by this paper
• Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis

  1998cited by this paper
• Systemic Short-Chain Fatty Acids Rapidly Alter Gastrointestinal Structure, Function, and Expression of Early Response Genes

  1998cited by this paper
• Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats.

  1998cited by this paper
• Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats.

  1997cited by this paper
• Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis.

  1997cited by this paper
• Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation.

  1996cited by this paper
• Treatment of distal ulcerative colitis with short-chain fatty acid enemas a placebo-controlled trial

  1996cited by this paper
• Fecal Short‐Chain Fatty Acids in Children with Inflammatory Bowel Disease

  1994cited by this paper
• Extrahepatic, differential expression of four classes of human alcohol dehydrogenase.

  1993cited by this paper
• Induction of cytochrome P‐4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA

  1993cited by this paper
• Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease.

  1993cited by this paper
• Parenteral nutrition supplemented with short-chain fatty acids: effect on the small-bowel mucosa in normal rats.

  1990cited by this paper
• The fermentation pathways of Escherichia coli.

  1989cited by this paper
• Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system.

  1988cited by this paper
• Studies of metabolites in diarrheal stool specimens containing Shigella species by frequency-pulsed electron capture gas-liquid chromatography

  1985cited by this paper
• Intestinal flora in health and disease.

  1984cited by this paper
• Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats.

  1983cited by this paper
• Observations of the formation of ethanol in the intestinal tract in man.

  1971cited by this paper
• ANAEROBIC DISSIMILATION OF GLUCOSE-C14 BY ESCHERICHIA COLI

  1961cited by this paper
• The formation of ethanol in Escherichia coli.

  1956cited by this paper

• Yuzhuo Zhixiao pill can treat non-alcoholic steatohepatitis through modulation of gut microbiota, bile acid and short-chain fatty acid metabolism.

  2025cites this paper
• SMALL INTESTINAL BACTERIAL OVERGROWTH IN THE INTESTINE AND MICROBIOME ALTERATIONS AS A RISK FACTOR FOR LIPID METABOLISM DISORDERS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE

  2025cites this paper
• Targeting regulation of lipid metabolism with polysaccharide of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease: A review.

  2025cites this paper
• Mechanism of liver x receptor alpha in intestine, liver and adipose tissues in metabolic associated fatty liver disease.

  2025cites this paper
• Gut Microbiota and Bile Acid Metabolism in the Mechanism of Ginsenoside Re Against Nonalcoholic Fatty Liver Disease

  2025cites this paper
• The current findings on the gut-liver axis and the molecular basis of NAFLD/NASH associated with gut microbiome dysbiosis

  2025cites this paper
• Ethanol-Producing Micro-Organisms of Human Gut: A Biological Phenomenon or a Disease?

  2025cites this paper
• “Trust your gut”: exploring the connection between gut microbiome dysbiosis and the advancement of Metabolic Associated Steatosis Liver Disease (MASLD)/Metabolic Associated Steatohepatitis (MASH): a systematic review of animal and human studies

  2025cites this paper
• Malnutrition induces steatohepatitis by impairing hepatic lipid metabolism, mitochondrial function and the gut-liver axis

  2025cites this paper
• Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults

  2024cites this paper
• Fructooligosaccharides Supplementation: A Good Choice for the Prevention and Treatment of Non-Alcoholic Fatty Liver Disease?

  2024cites this paper
• Effects of plant natural products on metabolic-associated fatty liver disease and the underlying mechanisms: a narrative review with a focus on the modulation of the gut microbiota

  2024cites this paper
• The Role of Gut Microbiota in Non-alcoholic Fatty Liver Disease Pathogenesis

  2024cites this paper
• The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies

  2024cites this paper
• Akkermansia muciniphila in patients with metabolic dysfunction-associated steatotic liver disease

  2024cites this paper
• Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier.

  2024cites this paper
• Prebiotics modulate the microbiota-gut-brain axis and ameliorate anxiety and depression-like behavior in HFD-fed mice.

  2024cites this paper
• Nobiletin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Gut Microbiota and Myristoleic Acid Metabolism.

  2023cites this paper
• Chronic jet lag alters gut microbiome and mycobiome and promotes the progression of MAFLD in HFHFD-fed mice

  2023cites this paper
• Physical exercise plays a role in rebalancing the bile acids of enterohepatic axis in non‐alcoholic fatty liver disease

  2023cites this paper
• Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children.

  2023cites this paper
• Сhanges in the composition of gut microbiota in patients with chronic hepatitis С, non-alcoholic fatty liver disease at different stages of liver disease: a review

  2023cites this paper
• Roles of human gut microbiota in liver cirrhosis risk: a two-sample mendelian randomization study.

  2023cites this paper
• Comprehensive analysis of the immunological differences in the intestinal barrier of improved grass carp and their parents

  2023cites this paper
• In Vitro Screening for Probiotic Properties of Lactobacillus and Bifidobacterium Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease Prevention

  2023cites this paper
• Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties

  2023cites this paper
• Tremella fuciformis Crude Polysaccharides Attenuates Steatosis and Suppresses Inflammation in Diet-Induced NAFLD Mice

  2022cites this paper
• Targeting keystone species helps restore the dysbiosis of butyrate‐producing bacteria in nonalcoholic fatty liver disease

  2022cites this paper
• The effects of fasting diets on nonalcoholic fatty liver disease.

  2022cites this paper
• Structural characteristics of polysaccharide from Zingiber striolatum and its effects on gut microbiota composition in obese mice

  2022cites this paper
• Two-week repair alleviates hexavalent chromium-induced hepatotoxicity, hepatic metabolic and gut microbial changes: A dynamic inhalation exposure model in male mice.

  2022cites this paper
• Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2/NLRP3 pathway

  2022cites this paper
• The Changes in Microbiotic Composition of Different Intestinal Tracts and the Effects of Supplemented Lactobacillus During the Formation of Goose Fatty Liver

  2022cites this paper
• Gut Microbiota Structure and Metabolites, Before and After Treatment in Early Rheumatoid Arthritis Patients: A Pilot Study

  2022cites this paper
• Quinoa bran soluble dietary fiber ameliorates dextran sodium sulfate induced ulcerative colitis in BALB/c mice by maintaining intestinal barrier function and modulating gut microbiota.

  2022cites this paper
• Alteration of fecal microbiome and metabolome by mung bean coat improves diet-induced non-alcoholic fatty liver disease in mice

  2022cites this paper
• Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting

  2022cites this paper
• Development, Characterization, and Investigation of In Vivo Targeted Delivery Efficacy of Luteolin-Loaded, Eudragit S100-Coated mPEG-PLGA Nanoparticles

  2022cites this paper
• Oxidative Stress in Non-Alcoholic Fatty Liver Disease

  2022cites this paper
• Treatment of Nonalcoholic Fatty Liver Disease through Changes in Gut Microbiome and Intestinal Epithelial Barrier

  2021cites this paper
• Endothelial‐immune crosstalk contributes to vasculopathy in nonalcoholic fatty liver disease

  2021cites this paper
• Association of small intestinal bacterial overgrowth with nonalcoholic fatty liver disease in children: A meta-analysis

  2021cites this paper
• Pivotal Dominant Bacteria Ratio and Metabolites Related to Healthy Body Index Revealed by Intestinal Microbiome and Metabolomics

  2021cites this paper
• Endotoxins and Non-Alcoholic Fatty Liver Disease

  2021cites this paper
• Probiotics and Prebiotics as a Strategy for Non-Alcoholic Fatty Liver Disease, a Narrative Review

  2021cites this paper
• Broccoli Florets Supplementation Improves Insulin Sensitivity and Alters Gut Microbiome Population—A Steatosis Mice Model Induced by High-Fat Diet

  2021cites this paper
• Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis

  2021influential citation
• Toll-Like Receptors Recognize Intestinal Microbes in Liver Cirrhosis

  2021cites this paper
• Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH

  2021cites this paper
• The deficit in folate and vitamin B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitis.

  2020cites this paper
• Basil Essential Oil and its Nanoemulsion Mitigate Non Alcoholic Steatohepatitis in Rat Model with Special Reference to Gut Microbiota.

  2020cites this paper
• Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know?

  2020cites this paper
• Non-alcoholic fatty liver disease in Morocco: The situation, the determinants and the challenges for health care

  2020cites this paper
• Variation in the gut microbial community is associated with the progression of liver regeneration

  2020cites this paper
• Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease

  2020cites this paper
• The Controversial Role of Human Gut Lachnospiraceae

  2020cites this paper
• Gut Microbiota and Liver Injury (II): Chronic Liver Injury.

  2020cites this paper
• Self-Balance of Intestinal Flora in Spouses of Patients With Rheumatoid Arthritis

  2020cites this paper
• The influence of dietary patterns on gut microbiome and its consequences for nonalcoholic fatty liver disease

  2020cites this paper
• The Response of the Gut Microbiota to Dietary Changes in the First Two Years of Life

  2020cites this paper
• Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.

  2020cites this paper
• Early prediction of liver disease using conventional risk factors and gut microbiome-augmented gradient boosting

  2020influential citation
• Identification of the keystone species in non-alcoholic fatty liver disease by causal inference and dynamic intervention modeling

  2020cites this paper
• The Association between Periodontitis and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.

  2020cites this paper
• Anti-NASH Drug Development Hitches a Lift on PPAR Agonism

  2019cites this paper
• Intestinally derived bacterial products stimulate development of nonalcoholic steatohepatitis

  2019cites this paper
• Relationship between intestinal microbial dysbiosis and primary liver cancer.

  2019cites this paper
• Traditional Chinese Medicine and Intestinal Microbiota: A Complementary and Integrative Health Approach to Ameliorate Obesity-Related Diseases.

  2019cites this paper
• The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD

  2019cites this paper
• Six-Week High-Fat Diet Alters the Gut Microbiome and Promotes Cecal Inflammation, Endotoxin Production, and Simple Steatosis without Obesity in Male Rats.

  2019cites this paper
• Pediatric NAFLD: an overview and recent developments in diagnostics and treatment

  2019cites this paper
• Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease

  2019cites this paper
• Gold Nanoparticles Cure Bacterial Infection with Benefit to Intestinal Microflora.

  2019cites this paper
• Depressionen und Lebererkrankungen: Die Rolle von Mikrobiom und Inflammation

  2019cites this paper
• Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota.

  2019cites this paper
• Practical Predictors of Fibrosis in Non-alcoholic Fatty Liver Disease : Immunoglobulin-A and HOMA-IR

  2019cites this paper
• Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD)

  2019cites this paper
• Microbiome diurnal rhythmicity and its impact on host physiology and disease risk

  2019cites this paper
• Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?

  2019cites this paper
• Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies

  2019cites this paper
• Mechanistic Studies of Cholesterol Lipotoxicity Pertinent to NASH

  2019cites this paper
• The Role of the Gut Microbiome and its Derived Mediators in Nonalcoholic Fatty Liver Disease

  2019cites this paper
• A Complementary and Integrative Health Approach to Ameliorate Obesity-Related Diseases

  2019cites this paper
• High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine.

  2018cites this paper
• Gut microbiome may contribute to insulin resistance and systemic inflammation in obese rodents: a meta-analysis.

  2018cites this paper
• Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT).

  2018cites this paper
• Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease

  2018cites this paper
• Ablating both Fabp1 and Scp2/Scpx (TKO) induces hepatic phospholipid and cholesterol accumulation in high fat-fed mice.

  2018cites this paper
• Correcting for batch effects in case-control microbiome studies

  2018cites this paper
• Analogy between non-alcoholic steatohepatitis (NASH) and hypertension: a stepwise patient-tailored approach for NASH treatment

  2018cites this paper
• Geniposide and Chlorogenic Acid Combination Ameliorates Non-alcoholic Steatohepatitis Involving the Protection on the Gut Barrier Function in Mouse Induced by High-Fat Diet

  2018cites this paper
• Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression

  2018cites this paper
• Multilocus sequence typing for Candida albicans strains from the intestinal tract of patients with cirrhosis.

  2018cites this paper
• Hepatic Steatosis—a complex interaction of germs, genes and grub.

  2018cites this paper
• Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?

  2018cites this paper
• Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression

  2018cites this paper
• Variation in the Plasma Levels of Polyunsaturated Fatty Acids in Control vis-à-vis Nonalcoholic Fatty Liver Disease Subjects and Its Possible Association with Gut Microbiome

  2018cites this paper
• Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats

  2018cites this paper
• “We are what our bacteria eat”: The role of bacteria in personalizing nutrition therapy in gastrointestinal conditions

  2017cites this paper
• Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach

  2017cites this paper